Onyx Drops Patent Lawsuit over Cancer Drug Nexavar against Dr. Reddy’s Lab
shot by IP News Shots / 4:32 pm on 22 November, 2021
Onyx Pharmaceuticals, Inc., a subsidiary of Amgen, Inc., and Bayer Healthcare, LLC has agreed to dismiss their patent infringement litigation against Dr. Reddy’s Laboratories, Inc. in the U.S. District Court for the District of Delaware. Onyx and Bayer accused Dr. Reddy’s over the generic version of Nexavar, a cancer drug used in the treatment of liver, kidney and thyroid cancer. The parties have discarded the case with prejudice, i.e., there will be no further litigation.
Industry: Biotechnology, Pharmaceuticals | News Category: Litigations | Type of IP: Patent
Read more at Reuters